2022 Q1 Form 10-Q Financial Statement

#000079417022000015 Filed on March 03, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q1
Revenue $1.791B $1.563B
YoY Change 14.56% 17.42%
Cost Of Revenue $1.389B $1.234B
YoY Change 12.62% 15.78%
Gross Profit $401.9M $329.8M
YoY Change 21.85% 23.99%
Gross Profit Margin 22.44% 21.1%
Selling, General & Admin $226.9M $210.7M
YoY Change 7.65% -3.57%
% of Gross Profit 56.44% 63.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.68M $16.88M
YoY Change -13.02% 15.06%
% of Gross Profit 3.65% 5.12%
Operating Expenses $226.9M $210.7M
YoY Change 7.65% -3.57%
Operating Profit $175.1M $119.1M
YoY Change 46.98% 150.78%
Interest Expense $23.60M $2.600M
YoY Change 807.69%
% of Operating Profit 13.48% 2.18%
Other Income/Expense, Net $3.712M $7.101M
YoY Change -47.73% 12.8%
Pretax Income $200.8M $127.4M
YoY Change 57.62% 93.24%
Income Tax $48.90M $30.90M
% Of Pretax Income 24.35% 24.25%
Net Earnings $151.9M $96.50M
YoY Change 57.42% 69.67%
Net Earnings / Revenue 8.48% 6.17%
Basic Earnings Per Share $1.26 $0.77
Diluted Earnings Per Share $1.24 $0.76
COMMON SHARES
Basic Shares Outstanding 121.0M shares 126.1M shares
Diluted Shares Outstanding 122.9M shares 127.6M shares

Balance Sheet

Concept 2022 Q1 2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $671.0M $950.0M
YoY Change -29.37% 82.69%
Cash & Equivalents $671.4M $949.7M
Short-Term Investments
Other Short-Term Assets $39.00M $29.00M
YoY Change 34.48% 16.0%
Inventory $8.584B $7.924B
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $9.726B $9.570B
YoY Change 1.63% 1.15%
LONG-TERM ASSETS
Property, Plant & Equipment $315.1M $277.7M
YoY Change 13.47% -2.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $680.0M $572.0M
YoY Change 18.88% 57.14%
Other Assets $159.0M $109.0M
YoY Change 45.87% -0.91%
Total Long-Term Assets $1.558B $1.294B
YoY Change 20.39% 14.9%
TOTAL ASSETS
Total Short-Term Assets $9.726B $9.570B
Total Long-Term Assets $1.558B $1.294B
Total Assets $11.28B $10.86B
YoY Change 3.86% 2.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $557.0M $460.0M
YoY Change 21.09% 46.5%
Accrued Expenses $1.198B $1.029B
YoY Change 16.42% 7.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.704B $2.213B
YoY Change 22.19% 23.42%
LONG-TERM LIABILITIES
Long-Term Debt $3.239B $3.736B
YoY Change -13.3% -7.41%
Other Long-Term Liabilities $39.00M $80.00M
YoY Change -51.25% 50.94%
Total Long-Term Liabilities $3.278B $3.816B
YoY Change -14.1% -6.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.704B $2.213B
Total Long-Term Liabilities $3.278B $3.816B
Total Liabilities $5.982B $6.030B
YoY Change -0.78% 2.51%
SHAREHOLDERS EQUITY
Retained Earnings $5.101B $5.246B
YoY Change -2.77% 8.92%
Common Stock $712.8M $710.2M
YoY Change 0.37% -1.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $563.6M $1.163B
YoY Change -51.53% 32.16%
Treasury Stock Shares 10.43M shares 29.98M shares
Shareholders Equity $5.256B $4.787B
YoY Change
Total Liabilities & Shareholders Equity $11.28B $10.86B
YoY Change 3.86% 2.61%

Cashflow Statement

Concept 2022 Q1 2021 Q1
OPERATING ACTIVITIES
Net Income $151.9M $96.50M
YoY Change 57.42% 69.67%
Depreciation, Depletion And Amortization $14.68M $16.88M
YoY Change -13.02% 15.06%
Cash From Operating Activities -$280.7M $55.32M
YoY Change -607.38% -115.1%
INVESTING ACTIVITIES
Capital Expenditures $18.48M $14.50M
YoY Change 27.45% -45.99%
Acquisitions
YoY Change
Other Investing Activities -$194.0K -$334.0K
YoY Change -41.92% -101.35%
Cash From Investing Activities -$62.36M -$9.781M
YoY Change 537.51% 362.24%
FINANCING ACTIVITIES
Cash Dividend Paid $21.08M $14.29M
YoY Change 47.55% -4.49%
Common Stock Issuance & Retirement, Net $128.1M $179.4M
YoY Change -28.61% -62.31%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$617.0M -$462.3M
YoY Change 33.48% 17.79%
NET CHANGE
Cash From Operating Activities -$280.7M $55.32M
Cash From Investing Activities -$62.36M -$9.781M
Cash From Financing Activities -$617.0M -$462.3M
Net Change In Cash -$960.1M -$416.7M
YoY Change 130.39% 5.62%
FREE CASH FLOW
Cash From Operating Activities -$280.7M $55.32M
Capital Expenditures $18.48M $14.50M
Free Cash Flow -$299.2M $40.83M
YoY Change -832.78% -110.38%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000794170
CY2022Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 dei Amendment Flag
AmendmentFlag
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
117299000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127937000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127937000 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
10426000 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7820000 shares
us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
CY2021Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrentAndNoncurrent
CY2022Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrentAndNoncurrent
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2022Q1 dei Document Type
DocumentType
10-Q
CY2022Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q1 dei Document Period End Date
DocumentPeriodEndDate
2022-01-31
CY2022Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q1 dei Entity File Number
EntityFileNumber
001-09186
CY2022Q1 dei Entity Registrant Name
EntityRegistrantName
Toll Brothers, Inc.
CY2022Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-2416878
CY2022Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1140 Virginia Drive
CY2022Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Fort Washington
CY2022Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19034
CY2022Q1 dei City Area Code
CityAreaCode
215
CY2022Q1 dei Local Phone Number
LocalPhoneNumber
938-8000
CY2022Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2022Q1 dei Trading Symbol
TradingSymbol
TOL
CY2022Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q1 dei Entity Shell Company
EntityShellCompany
false
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
117299000 shares
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
671365000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1638494000 USD
CY2022Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
8584427000 USD
CY2021Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7915884000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
315098000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
310455000 USD
CY2022Q1 tol Receivablesprepaidexpensesandotherassets
Receivablesprepaidexpensesandotherassets
743368000 USD
CY2021Q4 tol Receivablesprepaidexpensesandotherassets
Receivablesprepaidexpensesandotherassets
738078000 USD
CY2022Q1 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
137210000 USD
CY2021Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
247211000 USD
CY2022Q1 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
106884000 USD
CY2021Q4 us-gaap Earnest Money Deposits
EarnestMoneyDeposits
88627000 USD
CY2022Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
679643000 USD
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
599101000 USD
CY2022Q1 us-gaap Income Tax Receivable
IncomeTaxReceivable
45884000 USD
CY2021Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
0 USD
CY2022Q1 us-gaap Assets
Assets
11283879000 USD
CY2021Q4 us-gaap Assets
Assets
11537850000 USD
CY2022Q1 us-gaap Loans Payable
LoansPayable
1143248000 USD
CY2021Q4 us-gaap Loans Payable
LoansPayable
1011534000 USD
CY2022Q1 us-gaap Senior Notes
SeniorNotes
1994544000 USD
CY2021Q4 us-gaap Senior Notes
SeniorNotes
2403989000 USD
CY2022Q1 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
101615000 USD
CY2021Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
147512000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
732254000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
636379000 USD
CY2022Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
557272000 USD
CY2021Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
562466000 USD
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1236425000 USD
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1220235000 USD
CY2022Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
217071000 USD
CY2021Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
215280000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
5982429000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
6197395000 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
1279000 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1279000 USD
CY2022Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
711558000 USD
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
714453000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5100841000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4969839000 USD
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
563618000 USD
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
391656000 USD
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5811000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1109000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5255871000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
5295024000 USD
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
175067000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
119110000 USD
CY2022Q1 us-gaap Minority Interest
MinorityInterest
45579000 USD
CY2021Q4 us-gaap Minority Interest
MinorityInterest
45431000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5301450000 USD
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5340455000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11283879000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11537850000 USD
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1791081000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1563376000 USD
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1389144000 USD
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1233527000 USD
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
226870000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
210739000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
22037000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1194000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3712000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7101000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
200816000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
127405000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48912000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30906000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
151904000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
96499000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4702000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
713000 USD
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
156606000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
97212000 USD
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.26
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.76
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120996000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126060000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122858000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127562000 shares
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5340455000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
151904000 USD
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
185768000 USD
CY2022Q1 tol Exercise Of Stock Options Stock Based Compensation Issuances And Employee Stock Purchase Plan Issuances
ExerciseOfStockOptionsStockBasedCompensationIssuancesAndEmployeeStockPurchasePlanIssuances
-2704000 USD
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13615000 USD
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
20902000 USD
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4702000 USD
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
21000 USD
CY2022Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
127000 USD
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
5301450000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4927476000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
96499000 USD
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13615000 USD
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
179395000 USD
CY2021Q1 tol Exercise Of Stock Options Stock Based Compensation Issuances And Employee Stock Purchase Plan Issuances
ExerciseOfStockOptionsStockBasedCompensationIssuancesAndEmployeeStockPurchasePlanIssuances
-4400000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12834000 USD
CY2021Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
14055000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
712000 USD
CY2021Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-21000 USD
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
4563000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4834492000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
151904000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
96499000 USD
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
14679000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16876000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12834000 USD
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
22037000 USD
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1194000 USD
CY2022Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
38279000 USD
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-2372000 USD
CY2021Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3617000 USD
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
565482000 USD
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
23502000 USD
CY2021Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
1080000 USD
CY2022Q1 tol Change In Deferred Tax Asset
ChangeInDeferredTaxAsset
2408000 USD
CY2021Q1 tol Change In Deferred Tax Asset
ChangeInDeferredTaxAsset
1277000 USD
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
2233000 USD
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
1267000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
274327000 USD
CY2022Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
412955000 USD
CY2021Q1 us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
376036000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
520370000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
478982000 USD
CY2022Q1 tol Increase Decrease In Receivables Prepaid Expenses And Other Assets
IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssets
6557000 USD
CY2021Q1 tol Increase Decrease In Receivables Prepaid Expenses And Other Assets
IncreaseDecreaseInReceivablesPrepaidExpensesAndOtherAssets
-34733000 USD
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
48074000 USD
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
3421000 USD
CY2022Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
77618000 USD
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
60580000 USD
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-34294000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
40835000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-280698000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
55323000 USD
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18475000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14496000 USD
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
109866000 USD
CY2021Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
112828000 USD
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
65792000 USD
CY2021Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
37853000 USD
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
79356000 USD
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-194000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-334000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62355000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9781000 USD
CY2022Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
766858000 USD
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
597973000 USD
CY2022Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
822142000 USD
CY2021Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
847415000 USD
CY2022Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
409856000 USD
CY2021Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
10020000 USD
CY2022Q1 tol Paymentsproceedsfromstockbasedbenefitplans
Paymentsproceedsfromstockbasedbenefitplans
-2701000 USD
CY2021Q1 tol Paymentsproceedsfromstockbasedbenefitplans
Paymentsproceedsfromstockbasedbenefitplans
-4397000 USD
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
128069000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
179395000 USD
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
21077000 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
14285000 USD
CY2022Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-61000 USD
CY2021Q1 us-gaap Proceeds From Payments To Minority Shareholders
ProceedsFromPaymentsToMinorityShareholders
-4728000 USD
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-617048000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-462267000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-960101000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-416725000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1684412000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1396604000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
724311000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
979879000 USD
CY2022Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
732300000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
636400000 USD
CY2022Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationCertain prior period amounts have been reclassified to conform to the fiscal 2022 presentation.
CY2022Q1 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
8584427000 USD
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
1267000 USD
CY2021Q4 us-gaap Inventory Operative Builders
InventoryOperativeBuilders
7915884000 USD
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
2233000 USD
CY2021Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
253938000 USD
CY2020Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
297975000 USD
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
31005000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
41268000 USD
CY2022Q1 tol Real Estate Inventory Capitalized Interest Unconsolidated Entities
RealEstateInventoryCapitalizedInterestUnconsolidatedEntities
-1290000 USD
CY2021Q1 tol Real Estate Inventory Capitalized Interest Unconsolidated Entities
RealEstateInventoryCapitalizedInterestUnconsolidatedEntities
-1134000 USD
CY2022Q1 tol Real Estate Inventory Capitalized Interest Unconsolidated Entities Transferto Inventory
RealEstateInventoryCapitalizedInterestUnconsolidatedEntitiesTransfertoInventory
135000 USD
CY2021Q1 tol Real Estate Inventory Capitalized Interest Unconsolidated Entities Transferto Inventory
RealEstateInventoryCapitalizedInterestUnconsolidatedEntitiesTransfertoInventory
15000 USD
CY2022Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
247942000 USD
CY2021Q1 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
302961000 USD
CY2022Q1 tol Numberof Joint Ventures
NumberofJointVentures
55 joint_ventures
CY2022Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
679643000 USD
CY2022Q1 tol Numberofjointventurewithfundingcommitments
Numberofjointventurewithfundingcommitments
26 joint_ventures
CY2022Q1 us-gaap Other Commitment
OtherCommitment
188141000 USD
CY2022Q1 tol Numberofjointventureswithloancommitments
Numberofjointventureswithloancommitments
34 joint_ventures
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2815981000 USD
CY2022Q1 us-gaap Line Of Credit
LineOfCredit
1768202000 USD
CY2021Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1220235000 USD
CY2022Q1 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
21200000 USD
CY2021Q4 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
16500000 USD
CY2022Q1 us-gaap Loss Contingency Receivable
LossContingencyReceivable
15126000 USD
CY2021Q4 us-gaap Loss Contingency Receivable
LossContingencyReceivable
16773000 USD
CY2022Q1 us-gaap Deposits Assets
DepositsAssets
68532000 USD
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
67626000 USD
CY2022Q1 us-gaap Escrow Deposit
EscrowDeposit
51683000 USD
CY2021Q4 us-gaap Escrow Deposit
EscrowDeposit
41429000 USD
CY2022Q1 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
348624000 USD
CY2021Q4 us-gaap Inventory Land Held For Development And Sale
InventoryLandHeldForDevelopmentAndSale
381401000 USD
CY2022Q1 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
38574000 USD
CY2021Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
34960000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
98923000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
96276000 USD
CY2022Q1 us-gaap Other Assets
OtherAssets
121906000 USD
CY2021Q4 us-gaap Other Assets
OtherAssets
99613000 USD
CY2022Q1 tol Receivablesprepaidexpensesandotherassets
Receivablesprepaidexpensesandotherassets
743368000 USD
CY2021Q4 tol Receivablesprepaidexpensesandotherassets
Receivablesprepaidexpensesandotherassets
738078000 USD
CY2022Q1 us-gaap Other Loans Payable
OtherLoansPayable
495624000 USD
CY2021Q4 us-gaap Other Loans Payable
OtherLoansPayable
364042000 USD
CY2022Q1 us-gaap Loans Payable
LoansPayable
1143248000 USD
CY2021Q4 us-gaap Loans Payable
LoansPayable
1011534000 USD
CY2022Q1 tol Number Of Issuances Of Senior Debt
NumberOfIssuancesOfSeniorDebt
5 debtissuances
CY2022Q1 tol Land Land Development And Construction Related Liabilities Current And Noncurrent
LandLandDevelopmentAndConstructionRelatedLiabilitiesCurrentAndNoncurrent
298390000 USD
CY2021Q4 tol Land Land Development And Construction Related Liabilities Current And Noncurrent
LandLandDevelopmentAndConstructionRelatedLiabilitiesCurrentAndNoncurrent
310996000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
176256000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current And Noncurrent
EmployeeRelatedLiabilitiesCurrentAndNoncurrent
232161000 USD
CY2022Q1 us-gaap Deposit Liability Current
DepositLiabilityCurrent
46159000 USD
CY2021Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
36107000 USD
CY2022Q1 tol Insurance And Litigation Liabilities Current And Noncurrent
InsuranceAndLitigationLiabilitiesCurrentAndNoncurrent
239194000 USD
CY2021Q4 tol Insurance And Litigation Liabilities Current And Noncurrent
InsuranceAndLitigationLiabilitiesCurrentAndNoncurrent
236369000 USD
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
143043000 USD
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
145062000 USD
CY2022Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
119851000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
116248000 USD
CY2022Q1 us-gaap Deferred Revenue
DeferredRevenue
38515000 USD
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
36638000 USD
CY2022Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
35762000 USD
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
34033000 USD
CY2022Q1 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
29969000 USD
CY2021Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
22150000 USD
CY2022Q1 tol Treasury Share Purchases Accrued
TreasurySharePurchasesAccrued
57699000 USD
CY2021Q4 tol Treasury Share Purchases Accrued
TreasurySharePurchasesAccrued
0 USD
CY2022Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
51587000 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
50471000 USD
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1236425000 USD
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
145062000 USD
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
157351000 USD
CY2022Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
9455000 USD
CY2021Q1 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
7402000 USD
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
14431000 USD
CY2021Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
15070000 USD
CY2022Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
143043000 USD
CY2021Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
150877000 USD
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48900000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
30900000 USD
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.243
CY2022Q1 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.052
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.058
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
5900000 USD
CY2022Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13615000 USD
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12834000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3413000 USD
CY2021Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
3289000 USD
CY2022Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
24400000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
14700000 USD
CY2022Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
3013000 shares
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
4027000 shares
CY2022Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
61.65
CY2021Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
44.54
CY2022Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
9550000 shares
CY2021Q1 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
15957000 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.17
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.11
CY2022Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5811000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6486000 USD
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
151904000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
96499000 USD
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
120996000 shares
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
126060000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1862000 shares
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1502000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
122858000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127562000 shares
CY2022Q1 tol Shares Issued Under Stock Incentive And Employee Stock Purchase Plans
SharesIssuedUnderStockIncentiveAndEmployeeStockPurchasePlans
408000 shares
CY2021Q1 tol Shares Issued Under Stock Incentive And Employee Stock Purchase Plans
SharesIssuedUnderStockIncentiveAndEmployeeStockPurchasePlans
456000 shares
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1558000 USD
CY2021Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1455000 USD
CY2022Q1 tol Incomefrom Ancillary Businesses
IncomefromAncillaryBusinesses
1960000 USD
CY2021Q1 tol Incomefrom Ancillary Businesses
IncomefromAncillaryBusinesses
6859000 USD
CY2022Q1 tol Other Misc Income
OtherMiscIncome
-1144000 USD
CY2021Q1 tol Other Misc Income
OtherMiscIncome
-1330000 USD
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3712000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7101000 USD
CY2022Q1 tol Revenuefrom Ancillary Business
RevenuefromAncillaryBusiness
27697000 USD
CY2021Q1 tol Revenuefrom Ancillary Business
RevenuefromAncillaryBusiness
29101000 USD
CY2022Q1 tol Expensesfrom Ancillary Businesses
ExpensesfromAncillaryBusinesses
25737000 USD
CY2021Q1 tol Expensesfrom Ancillary Businesses
ExpensesfromAncillaryBusinesses
22242000 USD
CY2022Q1 us-gaap Purchase Obligation
PurchaseObligation
4653967000 USD
CY2021Q4 us-gaap Purchase Obligation
PurchaseObligation
4452757000 USD
CY2022Q1 us-gaap Purchase Obligation
PurchaseObligation
4653967000 USD
CY2021Q4 us-gaap Purchase Obligation
PurchaseObligation
4452757000 USD
CY2022Q1 tol Number Of Homes To Be Delivered
NumberOfHomesToBeDelivered
11302 luxury_homes
CY2022Q1 us-gaap Inventory Write Down
InventoryWriteDown
2233000 USD
CY2022Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
94577000 USD
CY2022Q1 tol Sales Value Of Outstanding Deliver Homes
SalesValueOfOutstandingDeliverHomes
10800000000 USD
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
33050000 USD
CY2022Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 joint_ventures
CY2022Q1 tol Numberofgeographicsegments
Numberofgeographicsegments
5 joint_ventures
CY2022Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1791081000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1563376000 USD
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
200816000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
127405000 USD
CY2022Q1 us-gaap Assets
Assets
11283879000 USD
CY2021Q4 us-gaap Assets
Assets
11537850000 USD
CY2021Q1 us-gaap Inventory Write Down
InventoryWriteDown
1267000 USD
CY2022Q1 us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
123176000 USD
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Inventory Acquired1
NoncashOrPartNoncashAcquisitionInventoryAcquired1
40511000 USD
CY2022Q1 tol Accrued Treasury Share Purchases
AccruedTreasurySharePurchases
57699000 USD
CY2021Q1 tol Accrued Treasury Share Purchases
AccruedTreasurySharePurchases
0 USD
CY2022Q1 us-gaap Contribution Of Property
ContributionOfProperty
556000 USD
CY2021Q1 us-gaap Contribution Of Property
ContributionOfProperty
49979000 USD
CY2022Q1 tol Non Cash Transfer Of Other Assets To Investment In Unconsolidated Entities
NonCashTransferOfOtherAssetsToInvestmentInUnconsolidatedEntities
36154000 USD
CY2021Q1 tol Non Cash Transfer Of Other Assets To Investment In Unconsolidated Entities
NonCashTransferOfOtherAssetsToInvestmentInUnconsolidatedEntities
13228000 USD
CY2022Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
6022000 USD
CY2021Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
522000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
671365000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
949696000 USD
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
52946000 USD
CY2021Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
30183000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
724311000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
979879000 USD

Files In Submission

Name View Source Status
0000794170-22-000015-index-headers.html Edgar Link pending
0000794170-22-000015-index.html Edgar Link pending
0000794170-22-000015.txt Edgar Link pending
0000794170-22-000015-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tol-20210131x10qxex3101.htm Edgar Link pending
tol-20210131x10qxex3102.htm Edgar Link pending
tol-20210131x10qxex3201.htm Edgar Link pending
tol-20210131x10qxex3202.htm Edgar Link pending
tol-20220131.htm Edgar Link pending
tol-20220131.xsd Edgar Link pending
tol-20220131_cal.xml Edgar Link unprocessable
tol-20220131_def.xml Edgar Link unprocessable
tol-20220131_htm.xml Edgar Link completed
tol-20220131_lab.xml Edgar Link unprocessable
tol-20220131_pre.xml Edgar Link unprocessable